IMCR

Immunocore Holdings Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 7/10
  • Value↓ 1/10
Immunocore Holdings sales and earnings growth
IMCR Growth
Good
  • Revenue Y/Y↑ 23.75%
  • EPS Y/Y↓ -25.58%
  • FCF Y/Y↓ -217.86%
Immunocore Holdings gross and profit margin trends
IMCR Profitability
Neutral
  • Gross margin ↑ 98.90%
  • EPS margin↓ -6.70%
  • ROIC 5Y↓ -15.78%
Immunocore Holdings net debt vs free cash flow
IMCR Risk
Great
  • Debt / Equity↓ 1.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ 0.0

Immunocore Holdings stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks